All News

Clinicians are becoming increasingly concerned about evidence that COVID-19 could also be a thromboembolic disease.

An issue that pharmacists might increasingly encounter deals with medical assistance in dying, where patients seek medical assistance to end their lives.

Advancing the role of the pharmacy technician allows for the profession’s advancement in providing patient care.

Increasing education and recommendations is a crucial element of increasing maternal vaccination.

Previous clinical trials have shown that SGLT2 inhibitors protect kidney, or renal, function among patients with T2D, but their effect on serious renal events in patients in real-world clinical practice remains unclear.

Researchers examined the long-term relationship between eating foods containing flavonoids and the risk of AD and AD-related dementias (ADRD).

Today, we’re celebrating the entire pharmacy team at Consonus Pharmacy in Las Vegas, Nevada.

Non-small cell lung cancer is a the most common type of lung cancer with up to 90% of all lung carcinomas falling into the non-small cell category.

Clearly identifying medications requiring special handling, such as those covered by USP , is important for the safety of your staff and patients.

"Approximately 40% of melanomas are considered to be ‘cold,’ meaning that they lack sufficient infiltration of immune cells within the tumor."

A majority of the patients who responded maintained their response for at least 1 year.

This discovery is an initial step toward developing a fully human antibody to treat or prevent the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, according to the study authors.

Researchers may be able to isolate reservoir cells from patients using the CD127 protein, which would make it possible to study what allows the cells to silence and reactivate the virus .

Today, we’re celebrating Shennel Sankar, PharmD, a staff pharmacist at Walmart Pharmacy.

Former interim chair of the Democratic National Committee Donna Brazile and former chairman of the Republican National Committee Michael Steele will give a joint keynote presentation on the current and future political landscape.

In a new study, researchers analyzed data on cancer survivors' experiences with financial toxicity and found that survivors have unmet needs in its management.

The drug is co-formulated with recombinant human hyaluronidase PH20 and will be available as soon as the week of May 11.

The day-to-day tasks of a pharmacy technician in a hospital are unique to that environment.

Researchers have developed a new way to map the molecules on tumor cells that flag their presence to the immune system.

A phase 3 trial showed a statistically significant and clinically meaningful decline in CV death or hospitalization from heart failure with dapagliflozin compared with placebo.

The Israel Institute for Biological Research presented the country’s Defense Minister Naftali Bennet with a “significant breakthrough” in the search for an antidote to COVID-19 on Monday night.

A recent survey identified the most substantial barriers to routine monitoring and follow-up for diabetes patients.

The National Institutes of Health (NIH) has issued a timely statement emphasizing the importance of asthma awareness and standing with parents, families, advocates, researchers, and health care professionals.

Lifestyle classes, or cardiac rehabilitation, are typically offered to heart attack patients unless the patient has a particular reason why it is not suitable for them.

Mathematicians at Cornell University are using game theory to model how cancer treatment may be administered more sparingly with maximized effect.

Dr. John J. Sciarra was a long time editor and contributor for Pharmacy Times during the 1980s and 1990s.

Today, we’re thanking Emily Friedman, RPh, PharmD, MBA, for her work opening testing sites and keeping her staff safe during the COVID-19 pandemic.

The findings are part of the I-SPY clinical trial and were presented at the American Association for Cancer Research virtual annual meeting.

A study to help determine the incidence rate of the coronavirus disease 2019 (COVID-19) in children and their family members has begun enrolling participants in the United States, according to the National Institutes of Health (NIH).